Renée Tsolis

Renée Tsolis

Auto-generated profile, based on publicly available information

Renée Tsolis

Department of Medical Microbiology and Immunology, University of California at Davis

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2010 in Nature
Verified
Journal Article
Open access
PDF file
SWSebastian E. Winter
Sebastian E. Winter
PTParameth Thiennimitr
Parameth Thiennimitr
MWMaria G. Winter
Maria G. Winter
BBBrian P. Butler
Brian P. Butler
DHDouglas L. Huseby
Douglas L. Huseby
ABAndreas J. Bäumler
Andreas J. Bäumler
Salmonella enterica serotype Typhimurium (S. Typhimurium) causes acute gut inflammation by using its virulence factors to invade the intestinal epithelium and survive in mucosal macrophages. The inflammatory response enhances the transmission success of S. Typhimurium by promoting its outgrowth in the gut lumen through unknown mechanisms. Here we show that reactive oxygen species generated during inflammation react with endogenous, luminal sulphur compounds (thiosulphate) to form a new respiratory electron acceptor, tetrathionate. The genes conferring the ability to use tetrathionate as an electron acceptor produce a growth advantage for S. Typhimurium over the competing microbiota in the lumen of the inflamed gut. We conclude that S. Typhimurium virulence factors induce host-driven production of a new electron acceptor that allows the pathogen to use respiration to compete with fermenting gut microbes. Thus the ability to trigger intestinal inflammation is crucial for the biology of this diarrhoeal pathogen.

11 August 2017 in Science
Verified
Journal Article
Closed access
PDF file
MBMariana X. Byndloss
Mariana X. Byndloss
EOErin E. Olsan
Erin E. Olsan
FRFabian Rivera-Chávez
Fabian Rivera-Chávez
CTConnor R. Tiffany
Connor R. Tiffany
SCStephanie A. Cevallos
Stephanie A. Cevallos
ABAndreas J. Bäumler
Andreas J. Bäumler
Healthy guts exclude oxygen: Normally, the lumen of the colon lacks oxygen. Fastidiously anaerobic butyrate-producing bacteria thrive in the colon; by ablating these organisms, antibiotic treatment removes butyrate. Byndloss et al. discovered that loss of butyrate deranges metabolic signaling in gut cells (see the Perspective by Cani). This induces nitric oxidase to generate nitrate in the lumen and disables β-oxidation in epithelial cells that would otherwise mop up stray oxygen before it enters the colon. Simultaneously, regulatory T cells retreat, and inflammation is unchecked, which contributes yet more oxygen species to the colon. Then, facultative aerobic pathogens, such as Escherichia coli and Salmonella enterica , can take advantage of the altered environment and outgrow any antibiotic-crippled and benign anaerobes. Science , this issue p. 570 ; see also p. 548

8 February 2013 in Science
Verified
Journal Article
Closed access
PDF file
SWSebastian E. Winter
Sebastian E. Winter
MWMaria G. Winter
Maria G. Winter
MXMariana N. Xavier
Mariana N. Xavier
PTParameth Thiennimitr
Parameth Thiennimitr
VPVictor Poon
Victor Poon
ABAndreas J. Bäumler
Andreas J. Bäumler
E. coli kNOws How to Win: The harmonious existence among the various microbial inhabitants of the gut is critical for good health. However, inflammation from injury or inflammatory bowel disease, can disrupt this balance and lead to the outgrowth of particular bacteria. The outgrowth of members of the Enterobacteriaceae family, which includes Escherichia coli , is often observed. Because E. coli are facultative rather an obligate anaerobes, Winter et al. (p. 708 ) postulated that they may be able to use by-products of reactive oxygen and nitrogen species, which are produced during inflammation, for anaerobic respiration, thereby edging out other fermenting bacteria. Indeed, in two mouse models of colitis and in a model of intestinal injury, various E. coli strains were able to use host-derived nitrate as an energy source and outcompete mutant strains unable to do this.

1 October 2017 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
YLYael Litvak
Yael Litvak
MBMariana X Byndloss
Mariana X Byndloss
RTRenée M Tsolis
Renée M Tsolis
ABAndreas J Bäumler
Andreas J Bäumler

3 October 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PTParameth Thiennimitr
Parameth Thiennimitr
SWSebastian E. Winter
Sebastian E. Winter
MWMaria G. Winter
Maria G. Winter
MXMariana N. Xavier
Mariana N. Xavier
Vladimir TolstikovVladimir Tolstikov
Vladimir Tolstikov
ABAndreas J. Bäumler
Andreas J. Bäumler
Conventional wisdom holds that microbes support their growth in vertebrate hosts by exploiting a large variety of nutrients. We show here that use of a specific nutrient (ethanolamine) confers a marked growth advantage on Salmonella enterica serovar Typhimurium ( S. Typhimurium) in the lumen of the inflamed intestine. In the anaerobic environment of the gut, ethanolamine supports little or no growth by fermentation. However, S. Typhimurium is able to use this carbon source by inducing the gut to produce a respiratory electron acceptor (tetrathionate), which supports anaerobic growth on ethanolamine. The gut normally converts ambient hydrogen sulfide to thiosulfate, which it then oxidizes further to tetrathionate during inflammation. Evidence is provided that S. Typhimurium's growth advantage in an inflamed gut is because of its ability to respire ethanolamine, which is released from host tissue, but is not utilizable by competing bacteria. By inducing intestinal inflammation, S. Typhimurium sidesteps nutritional competition and gains the ability to use an abundant simple substrate, ethanolamine, which is provided by the host.

23 March 2016 in Nature
Verified
Journal Article
Open access
PDF file
AKA. Marijke Keestra-Gounder
A. Marijke Keestra-Gounder
MBMariana X. Byndloss
Mariana X. Byndloss
NSNúbia Seyffert
Núbia Seyffert
BYBriana M. Young
Briana M. Young
ACAlfredo Chávez-Arroyo
Alfredo Chávez-Arroyo
RTRenée M. Tsolis
Renée M. Tsolis
A novel link between the unfolded protein response and NOD1/2 innate immune signalling, showing that NOD1/2 are required for ER-stress-induced IL-6 production in response to infection with Brucella abortus. Inflammation due to endoplasmic reticulum (ER) stress is seen in a number of inflammatory diseases, including Crohn's disease and type 2 diabetes and ulcerative colitis. These authors show that activation of ER stress during infection with Brucella abortus is a pathogen-induced process that is sensed by the NOD1 and NOD2 proteins, two pathogen recognition receptors that induce pro-inflammatory responses mediated by activation of NF-κB. Endoplasmic reticulum (ER) stress is a major contributor to inflammatory diseases, such as Crohn disease and type 2 diabetes1,2. ER stress induces the unfolded protein response, which involves activation of three transmembrane receptors, ATF6, PERK and IRE1α3. Once activated, IRE1α recruits TRAF2 to the ER membrane to initiate inflammatory responses via the NF-κB pathway4. Inflammation is commonly triggered when pattern recognition receptors (PRRs), such as Toll-like receptors or nucleotide-binding oligomerization domain (NOD)-like receptors, detect tissue damage or microbial infection. However, it is not clear which PRRs have a major role in inducing inflammation during ER stress. Here we show that NOD1 and NOD2, two members of the NOD-like receptor family of PRRs, are important mediators of ER-stress-induced inflammation in mouse and human cells. The ER stress inducers thapsigargin and dithiothreitol trigger production of the pro-inflammatory cytokine IL-6 in a NOD1/2-dependent fashion. Inflammation and IL-6 production triggered by infection with Brucella abortus, which induces ER stress by injecting the type IV secretion system effector protein VceC into host cells5, is TRAF2, NOD1/2 and RIP2-dependent and can be reduced by treatment with the ER stress inhibitor tauroursodeoxycholate or an IRE1α kinase inhibitor. The association of NOD1 and NOD2 with pro-inflammatory responses induced by the IRE1α/TRAF2 signalling pathway provides a novel link between innate immunity and ER-stress-induced inflammation.